People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Phenomix Sciences, Inc. | — | Other Health Care | Series A | $8.6M | $7.1M | 2023 |
| Phenomix Sciences LLC | — | Biotechnology | Seed | $1.1M | $48.8M | 2018 |
Andres Acosta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andres Acosta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Camilleri | 2 | 2 |
| LAWRENCE COHEN | 1 | 3 |
| Mark Bagnall | 1 | 3 |
| Karl Ronn | 1 | 2 |
| Lawrence K Cohen | 1 | 2 |
| Sean McCauley | 1 | 1 |
| Mark Bengall | 1 | 1 |
| William Ross Higgins | 1 | 1 |
| Paul Owen | 1 | 1 |
| Karl K Ronn | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.